Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H16N2O |
Molecular Weight | 204.2682 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCC1=CNC2=C1C(O)=CC=C2
InChI
InChIKey=SPCIYGNTAMCTRO-UHFFFAOYSA-N
InChI=1S/C12H16N2O/c1-14(2)7-6-9-8-13-10-4-3-5-11(15)12(9)10/h3-5,8,13,15H,6-7H2,1-2H3
Molecular Formula | C12H16N2O |
Molecular Weight | 204.2682 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Psilocin is a serotonergic psychedelic substance found in most psychedelic mushrooms along with its phosphorylated counterpart psilocybin. Psilocin is the pharmacologically active agent in the body after ingestion of psilocybin. Psilocybin rapidly dephosphorylates to psilocin which acts as a 5-HT2A, 5-HT2C, and 5-HT1A agonist or partial agonist.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q64264 Gene ID: 15550.0 Gene Symbol: Htr1a Target Organism: Mus musculus (Mouse) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21148021 |
49.0 nM [Ki] | ||
Target ID: P35363 Gene ID: 15558.0 Gene Symbol: Htr2a Target Organism: Mus musculus (Mouse) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21148021 |
25.0 nM [Ki] | ||
Target ID: P34968 Gene ID: 15560.0 Gene Symbol: Htr2c Target Organism: Mus musculus (Mouse) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21148021 |
10.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25342005
Rats were administered 5 and 10 mg/kg of Psilocin as an intraperitoneal injection. Following the dosing protocol, extracellular dopamine levels were increased in the nucleus accumbens. Psilocin did not affect the extracellular 5-HT level in the nucleus accumbens. However, systemic administration of 10 mg/kg of psilocin significantly increased extracellular 5-HT levels in the ventral tegmental area, but decreased dopamine in this area. Behaviorally, psilocin significantly increased the number of head twitches.
Route of Administration:
Intraperitoneal
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Jul 05 22:53:31 UTC 2023
by
admin
on
Wed Jul 05 22:53:31 UTC 2023
|
Record UNII |
CMS88KUW0G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
7438
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
||
|
WIKIPEDIA |
TiHKAL
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
208-296-5
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
100000085668
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
8613
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
SUB22051
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
PSILOCIN
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
CMS88KUW0G
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
520-53-6
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
4980
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
DTXSID5048899
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | |||
|
M9304
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY | Merck Index | ||
|
C009105
Created by
admin on Wed Jul 05 22:53:31 UTC 2023 , Edited by admin on Wed Jul 05 22:53:31 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
LABELED -> NON-LABELED |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|